In BCR-ABL positive cells, Gleevec (imatinib), an inhibitor of receptor tyrosine kinase, induces telomerase translocation out of the nucleolus, indicating that TERT phosphorylation can influence telomerase activity by altering its location in cancer cells, consistent with other findings [64, 89, 90]. Here, TERT is linked to cancer.